Daily Archives: May 12, 2014

Phoenicia's Lead Drug for Hemoglobinopathies selected by NIH-TRND Program

image1445 Phoenicia’s lead drug candidate for the treatment of β-thalassemia and sickle cell disease (PB-04), was recently selected as a project within the Therapeutics for Rare and Neglected Diseases program at the NIH’s National Center for Advancing Translational Sciences. Through our collaboration with TRND researchers, we gain access to preclinical drug development expertise. The goal of the TRND program is to work with collaborators to advance potential treatments to human clinical trials.